Tag Archives: chronic disease

Official: Deaths from COVID-19 highlight the need to control diabetes on the islands | Guam News | Instant News


Prior to the COVID-19 crisis, rates of diabetes and other chronic diseases were already high in the US-affiliated Pacific islands, regional health officials told the Rotary Club of Northern Guam on Wednesday.

But with many of the more than 100 deaths from COVID-19 in Guam linked to diabetes, the need to control diabetes has become much more urgent, they said.

Two officials from the Pacific Island Health Care Workers Association, or PIHOA, shared with Rotarians how prevalent diabetes, hypertension, cancer, heart disease, obesity and other non-communicable diseases are in the US-affiliated Pacific islands.

These islands include Guam, CNMI, American Samoa, Palau, Marshall Islands, and the Federated States of Micronesia.

There is well-established documentation in Guam that comorbidities such as diabetes and other chronic illnesses increase the risk of death from COVID-19, according to Janet Camacho, PIHOA deputy director of programs and operations for Honolulu.

From 2001 to 2019, the number of diabetes cases “has increased steadily” and has become one of the leading causes of death in Guam, said Cerina Mariano, PIHOA program and administrator of Guam operations.

This is based on data from the Guam Department of Public Health and Social Services, he said.

The behavioral risk survey, he said, also showed that 84% of respondents said they had never been told by a doctor that they had diabetes.

“Since this is a self-report, it is most likely underestimated,” said Mariano.

Risk factors

In Guam, diabetes risk factors include age, ethnicity, and education as well as income, he said.

According to the survey, more men than women have diabetes, and those 55 and over make up 50% of those with diabetes, Mariano said.

As far as ethnicity goes, being a Pacific islander – compared to white, black, American Indian or Native Alaskan and other ethnic groups – means a much higher risk of being diagnosed with diabetes, he said.

Socio-economic factors such as education and income also play a role due to limited access to health services and affordable healthy food.

Diabetes and other chronic diseases are not only common among adults on Guam, but also tend to start at a young age.

“About 40% of youth in Guam in 2019 reported being overweight or obese, and that number has been increasing over the years,” said Mariano.

A hybrid survey over the past five years among most of the US-affiliated Pacific islands shows that the prevalence of diabetes in adults on these islands is much higher than in the United States.

That’s mainly because of the island’s geographic isolation and limited resources, Mariano said.

1 in 4 people are treated

Only about one in four of those diagnosed with diabetes are on treatment, and of those on treatment, less than 10% are controlled on the islands, Mariano said.

“The situation is big enough to attract international attention,” he said.

Through partners such as the World Health Organization, Mariano said, FSM can receive more than 9,000 doses of insulin for diabetes from a company in Denmark.

But even just bringing insulin to the islands is a challenge. It had to be sent to Australia first, and then sent to San Francisco and then Guam, and finally to FSM, Mariano said.

Control diabetes

Hermie Queja, president of the Rotary Club of Northern Guam, said they plan to help raise awareness about diabetes among young people and look forward to partnering with entities like PIHOA.

PIHOA officials say diabetes awareness, prevention and treatment programs need more help.

The simplest steps a person can take to prevent diabetes or control it is to eat a healthy diet and be physically active, Mariano said.

.



image source

Science Advisory Board | Instant News


Science Advisory Board<br />

COVID-19 has long-term effects on the biotechnology industry

January 5, 2021 – The COVID-19 pandemic will have far-reaching and lasting effects on the biotechnology industry, according to speakers at a January 5 presentation held ahead of the virtual Biotech Showcase being held on January 11-15. Biotech companies have been swirling around on a large scale pursuing infectious disease research – and not all of them will succeed.
Discuss

An allergic reaction to the COVID-19 vaccine should not stop vaccination

January 4, 2021 – The COVID-19 vaccine currently approved for emergency use by the US Food and Drug Administration (FDA) is safe even among people with food or drug allergies, according to allergists from Massachusetts General Hospital. A review of all relevant information is published on Journal of Allergy and Clinical Immunology: In Practice on December 31st.
Discuss

Top 10 ScienceBoard stories for 2020

21 December 2020 – For many of us, 2020 didn’t go according to plan. The emergence of the COVID-19 pandemic has drastically changed our daily lives. Right here at ScienceBoard.net, we have provided our readers with timely and evidence-based information regarding COVID-19, as well as many other topics in the biopharmaceutical and life sciences industry.
Discuss

The FDA issued the EUA for the Moderna COVID-19 vaccine

18 December 2020 – Just one day after the committee’s favorable recommendation, the US Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for the COVID-19 messenger RNA (mRNA) vaccine from Moderna. The company’s mRNA-1273 vaccine is now the second COVID-19 vaccine on the US market, after vaccines from Pfizer and BioNTech were administered EUA last week.
Discuss

New discoveries could produce broad-spectrum antivirals

18 December 2020 – Scientists have identified key human genes that cells need to consume and destroy viruses. Research results are published in Natural on December 16 and could demonstrate new treatments to target viral infections, including COVID-19.
Discuss

The FDA committee voted in favor of the Moderna COVID-19 EUA vaccine

17 December 2020 – Moderna’s COVID-19 messenger RNA (mRNA) vaccine candidate, mRNA-1273, received favorable recommendations on December 17 from an advisory committee for the US Food and Drug Administration (FDA). The OK Committee means that mRNA-1273 may receive emergency use authorization (EUA) within a few days.
Discuss

The new immunotherapy supports the polio vaccine to treat cancer

17 December 2020 – As if we needed another reason to get vaccinated, researchers have developed technology that uses the polio vaccine to help treat cancer in those who later develop the disease. The technology, developed at Duke University and developed by Istari Oncology, uses the antigen produced by the polio vaccine to trigger the immune system to eat away at targeted cancer cells.
Discuss

The genes provide new targets for COVID-19 therapy

15 December 2020 – Genes associated with antiviral immunity and lung inflammation have been linked to severe cases of COVID-19 in a new genome analysis carried out in the UK. The result, published in Natural on December 11, revealed new therapeutic targets for drug reuse and development efforts.
Discuss

Global health R&D has stalled as resources shifted to COVID-19

December 14, 2020 – The current coronavirus pandemic has slowed progress in research and development (R&D) on neglected diseases and other long-term global health challenges by disrupting ongoing research and directing resources to the work of COVID-19, according to a new report released on December 11. by the nonprofit Global Health Technologies Coalition.
Discuss

The FDA issued the EUA for Pfizer’s vaccine, BioNTech COVID-19

12 December 2020 – The US Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine. This step comes after the FDA’s Vaccines and Biological Products Advisory Committee issued positive recommendations for the vaccine.

Google’s DeepMind is making a quantum leap in solving the problem of protein folding

11 December 2020 – Artificial intelligence has made breakthroughs in protein structure prediction. The results come as part of the 14th Critical Assessment of Structure Prediction, a friendly contest and conference organized by the Protein Structure Prediction Center with sponsorship from the National Institute of General Medical Sciences, part of the US National Institutes of Health.
Discuss






.



image source

Science Advisory Board | Instant News


Science Advisory Board<br />

The FDA committee voted in favor of the Moderna COVID-19 EUA vaccine

17 December 2020 – Moderna’s COVID-19 messenger RNA (mRNA) vaccine candidate, mRNA-1273, today received favorable recommendations from the advisory committee for the US Food and Drug Administration (FDA). The OK Committee means that mRNA-1273 may receive emergency use authorization (EUA) within a few days.
Discuss

The new immunotherapy supports the polio vaccine to treat cancer

17 December 2020 – As if we needed another reason to get vaccinated, researchers have developed technology that uses the polio vaccine to help treat cancer in those who later develop the disease. The technology, developed at Duke University and developed by Istari Oncology, uses the antigen produced by the polio vaccine to trigger the immune system to eat away at targeted cancer cells.
Discuss

The genes provide new targets for COVID-19 therapy

15 December 2020 – Genes linked to antiviral immunity and lung inflammation have been linked to severe cases of COVID-19 in a new genome analysis carried out in the UK. The result, published in Natural on December 11, revealed new therapeutic targets for drug reuse and development efforts.
Discuss

Global health R&D has stalled as resources shifted to COVID-19

December 14, 2020 – The current coronavirus pandemic has slowed progress in research and development (R&D) on neglected diseases and other long-term global health challenges by disrupting ongoing research and directing resources to the work of COVID-19, according to a new report released on December 11. by the nonprofit Global Health Technologies Coalition.
Discuss

The FDA issued the EUA for Pfizer’s vaccine, BioNTech COVID-19

12 December 2020 – The US Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine. This step comes after the FDA’s Vaccines and Biological Products Advisory Committee issued positive recommendations for the vaccine.

Google’s DeepMind is making a quantum leap in solving the problem of protein folding

11 December 2020 – Artificial intelligence has made breakthroughs in protein structure prediction. The results come as part of the 14th Critical Assessment of Structure Prediction, a friendly contest and conference organized by the Protein Structure Prediction Center with sponsorship from the National Institute of General Medical Sciences, part of the US National Institutes of Health.
Discuss

The FDA committee approved the transfer of Pfizer, the BioNTech COVID-19 vaccine to EUA

December 10, 2020 – Pfizer-BioNTech’s COVID-19 vaccine candidate, BNT162b2, passed an important milestone today when the US Food and Drug Administration (FDA) advisory committee determined that the candidate’s benefits in preventing COVID-19 outweigh the risks. The committee’s advice is likely to lead to the issuance of an emergency use authorization (EUA) for vaccines by the FDA within days.
Discuss

The new study found the SARS-CoV-2 antibodies disappeared rapidly

8 December 2020 – Antibodies developed after being infected with the SARS-CoV-2 virus disappeared rapidly, according to an analysis published in Immunology Science on December 7th. These findings may suggest that SARS-CoV-2 infection may not offer long-term immunity from subsequent reinfection with the virus.
Discuss

The new universal flu vaccine targets conserved areas of viral surface proteins

December 7, 2020 – A new universal influenza vaccine has been developed that targets the surface protein stem of the influenza virus rather than the head. This vaccine, which is capable of neutralizing various strains of influenza, was evaluated in a phase I clinical study whose results were published in Natural Medicine on December 7th.
Discuss

Regulatory Roundup: The appointment is made before the end of the year

December 7, 2020 – This week’s Regulatory Roundup covers activities from November 30 to December 4 and is filled with breakthroughs, orphans, and rare disease appointments from the US Food and Drug Administration and the European Medicines Agency. Several cancer, immunotherapy, and vaccine companies also submitted biological licensing applications to advance their candidates.
Discuss






.



image source

New Zealand First to announce Healthy Kiwi Package | Instant News


NZ First Party

New Zealand First has announced the ‘Healthy Kiwi Package’ at a public meeting in Rotorua. The ‘Healthy Kiwi Package’ is committed to;

  • Increase Pharmac funding to 1.4% of GDP by 2023, in line with the OECD average.
  • Extends free basic dental care for ages 18 to 25, Community Service Card holders, and SuperGold Card holders.
  • Provides free annual eye examinations for ages over 65
  • $ 10 million for free counseling sessions through I Am Hope
  • Committed to funding St John Ambulance Service as they request of us

“During this period, we have increased funds drastically to improve our health system, we have expanded free Doctor visits to children under 14 years and funded free annual health checks for SuperGold Cardholders. However, we still have more to do, ”said Leader of New Zealand First Winston Peters

“New Zealand’s Combined Pharmaceuticals budget underperformed, being funded up to 0.9% of GDP compared to our OECD counterparts. Raising these funds will give Kiwis greater access to the medicines they need to be healthy.

“We will set a transparent annual drug budget that includes new investment in community medicine and hospitals to meet the OECD average of up to 1.4% of GDP by 2023. This new investment includes the creation of a special rare disorder drugs fund. of $ 30 million per year, “said Mr. Peters

“Extend free dental care through free annual checkups, x-rays and cleaning for children aged 18-25 years, Community Service Cardholders and SuperGold Cardholders. This will be funded and provided in a community-based dental facility rather than burdening hospital services.

“Tooth decay is our most common chronic disease with 1.6 million New Zealanders not receiving dental care because of cost. We are committed to stopping preventable dental diseases that can impact chronic conditions such as diabetes, cardiovascular disease and kidney disease, ”said Peters.

“We have the terms of the coalition agreement to provide one free annual health check and eye test for over 65s. We have announced funding for annual health checks in Budget 2020 but need to secure eye tests. This is another preventive measure to stop preventable diseases and improve health outcomes.

“Earlier on the ‘Back Your Future’ bus tour we announced $ 10 million in free counseling sessions through I Am Hope / Gumboot Friday and committed to fully funding the St John Ambulance Service.

“Investing in our own health and well-being will reduce problems, and costs, in the future. Any responsible government will see that the Kiwi is our country’s greatest asset, so we need to invest in it, ”said Mr Peters.

Rt Hon Winston Peters, First New Zealand Leader

/ Public Release. Material in this public release comes from the original organization and may be point-in-time, edited for clarity, style and length. view more here.

.



image source

Family dog euthanized after testing positive for coronavirus | Instant News


Family in South Carolina made the difficult decision to put down their beloved family dog after the animal tested positive for SARS-coronavirus-2 – the virus which causes COVID-19 people, according to Clemson University.

According to Dr. Boyd Parr, state veterinarian and Director Clemson livestock poultry health (LPH), private vet decided to test a dog, nine-year-old shepherd mix – SARS-cov-2 after one of its owners was confirmed COVID-19.

While the family’s PET did test positive for the virus, the veterinary findings also showed the dog had a chronic disease.

Related: Euthanising pet owners for fear COVID-19 the distribution

The Department of agriculture (USDA) national veterinary laboratories confirmed the virus at a dog on July 9, according reports.

The investigation into this case is ongoing, led Clemson Le and the S. C. Department of health and environmental control (DHEC) along with the Ministry of agriculture of the USA and the American Center for control and prevention (CDC).

“Based on current knowledge, there is still no evidence that domestic animals play a significant role in the spread of SARS-coronavirus-2 for people,” said Parr.

“It’s still a good idea to limit contact with Pets and other animals as you do with other people if you are infected COVID-19 in order to protect them from exposure to the virus recommended by the CDC.”

Similar reports appeared in the midst of a pandemic coronavirus earlier this year. Sydney veterinarian Dr Sam Kovac says he was asked some customers if they have to euthanize their Pets amid growing concerns about the spread of coronavirus.

Related: As Wuhan coronavirus has jumped from animals to humans

Dr. Kovacs, a veterinarian who treats Pets in the Sydney city and inner West, said there was a surge of pet owners doubt that the virus can be transmitted from animals.

“These people who are so hysterical about the virus, which they consider euthanasia as a way to protect their families,” said Dr. Kovacs.

“The coronavirus in dogs is actually very common and very contagious, but only usually causes mild symptoms stomach, like diarrhea and vomiting (If no symptoms at all).”

“While no human cases of the coronavirus is transmitted from their Pets, mutations of the virus may happen that allows the virus to cross the species barrier, however, in all the hundreds of years of monitoring, this did not happen with dogs or cats coronavirus,” Dr. Kovacs confirmed post at southern Cross blog Vet.

.



image source